載入...
The Efficacy of Synchronous Combination of Chemotherapy and EGFR TKIs for the First-Line Treatment of NSCLC: A Systematic Analysis.
The combination of chemotherapy and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) currently has become the hotspot issue in the treatment of non-small lung cancer (NSCLC). This systematic review was conducted to compare the efficacy and safety of the synchronous combinati...
Na minha lista:
Main Authors: | , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Public Library of Science (PLoS)
2015-01-01
|
叢編: | PLoS ONE |
在線閱讀: | http://europepmc.org/articles/PMC4540576?pdf=render |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|